vs

Side-by-side financial comparison of Loar Holdings Inc. (LOAR) and MEDIFAST INC (MED). Click either name above to swap in a different company.

Loar Holdings Inc. is the larger business by last-quarter revenue ($131.8M vs $75.1M, roughly 1.8× MEDIFAST INC). On growth, Loar Holdings Inc. posted the faster year-over-year revenue change (19.3% vs -36.9%). Over the past eight quarters, Loar Holdings Inc.'s revenue compounded faster (19.8% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

LOAR vs MED — Head-to-Head

Bigger by revenue
LOAR
LOAR
1.8× larger
LOAR
$131.8M
$75.1M
MED
Growing faster (revenue YoY)
LOAR
LOAR
+56.2% gap
LOAR
19.3%
-36.9%
MED
Faster 2-yr revenue CAGR
LOAR
LOAR
Annualised
LOAR
19.8%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LOAR
LOAR
MED
MED
Revenue
$131.8M
$75.1M
Net Profit
$12.5M
Gross Margin
52.1%
69.4%
Operating Margin
18.0%
-10.4%
Net Margin
9.5%
Revenue YoY
19.3%
-36.9%
Net Profit YoY
239.5%
EPS (diluted)
$0.13
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOAR
LOAR
MED
MED
Q4 25
$131.8M
$75.1M
Q3 25
$126.8M
$89.4M
Q2 25
$123.1M
$105.6M
Q1 25
$114.7M
$115.7M
Q4 24
$110.4M
$119.0M
Q3 24
$103.5M
$140.2M
Q2 24
$97.0M
$168.6M
Q1 24
$91.8M
$174.7M
Net Profit
LOAR
LOAR
MED
MED
Q4 25
$12.5M
Q3 25
$27.6M
$-2.3M
Q2 25
$16.7M
$2.5M
Q1 25
$15.3M
$-772.0K
Q4 24
$3.7M
Q3 24
$8.7M
$1.1M
Q2 24
$7.6M
$-8.2M
Q1 24
$2.2M
$8.3M
Gross Margin
LOAR
LOAR
MED
MED
Q4 25
52.1%
69.4%
Q3 25
52.7%
69.5%
Q2 25
53.8%
72.6%
Q1 25
52.1%
72.8%
Q4 24
48.9%
74.1%
Q3 24
51.1%
75.4%
Q2 24
49.0%
73.2%
Q1 24
48.4%
72.8%
Operating Margin
LOAR
LOAR
MED
MED
Q4 25
18.0%
-10.4%
Q3 25
22.9%
-4.6%
Q2 25
22.2%
-1.0%
Q1 25
22.8%
-1.1%
Q4 24
19.2%
0.6%
Q3 24
22.1%
1.5%
Q2 24
22.9%
-4.7%
Q1 24
23.3%
4.5%
Net Margin
LOAR
LOAR
MED
MED
Q4 25
9.5%
Q3 25
21.8%
-2.5%
Q2 25
13.6%
2.3%
Q1 25
13.4%
-0.7%
Q4 24
3.3%
Q3 24
8.4%
0.8%
Q2 24
7.9%
-4.8%
Q1 24
2.4%
4.8%
EPS (diluted)
LOAR
LOAR
MED
MED
Q4 25
$0.13
$-1.64
Q3 25
$0.29
$-0.21
Q2 25
$0.17
$0.22
Q1 25
$0.16
$-0.07
Q4 24
$-11023.48
$0.08
Q3 24
$0.09
$0.10
Q2 24
$0.09
$-0.75
Q1 24
$11023.54
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOAR
LOAR
MED
MED
Cash + ST InvestmentsLiquidity on hand
$84.8M
$167.3M
Total DebtLower is stronger
$715.7M
Stockholders' EquityBook value
$1.2B
$198.9M
Total Assets
$2.0B
$248.0M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOAR
LOAR
MED
MED
Q4 25
$84.8M
$167.3M
Q3 25
$99.0M
$173.5M
Q2 25
$103.3M
$162.7M
Q1 25
$80.5M
$164.6M
Q4 24
$54.1M
$162.3M
Q3 24
$55.2M
$170.0M
Q2 24
$73.2M
$163.5M
Q1 24
$28.2M
$156.4M
Total Debt
LOAR
LOAR
MED
MED
Q4 25
$715.7M
Q3 25
$279.4M
Q2 25
$277.7M
Q1 25
$277.5M
Q4 24
$277.3M
Q3 24
$602.1M
Q2 24
$250.7M
Q1 24
$534.2M
Stockholders' Equity
LOAR
LOAR
MED
MED
Q4 25
$1.2B
$198.9M
Q3 25
$1.2B
$214.7M
Q2 25
$1.1B
$216.0M
Q1 25
$1.1B
$211.0M
Q4 24
$1.1B
$210.1M
Q3 24
$769.8M
$207.3M
Q2 24
$758.4M
$205.3M
Q1 24
$420.6M
$211.0M
Total Assets
LOAR
LOAR
MED
MED
Q4 25
$2.0B
$248.0M
Q3 25
$1.5B
$268.2M
Q2 25
$1.5B
$269.3M
Q1 25
$1.5B
$280.0M
Q4 24
$1.5B
$284.2M
Q3 24
$1.5B
$291.2M
Q2 24
$1.1B
$293.5M
Q1 24
$1.1B
$302.8M
Debt / Equity
LOAR
LOAR
MED
MED
Q4 25
0.61×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.25×
Q4 24
0.25×
Q3 24
0.78×
Q2 24
0.33×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LOAR
LOAR
MED
MED
Operating Cash FlowLast quarter
$30.4M
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
2.43×
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LOAR
LOAR
MED
MED
Q4 25
$30.4M
$-5.3M
Q3 25
$29.7M
$12.1M
Q2 25
$23.8M
$-3.4M
Q1 25
$28.4M
$3.4M
Q4 24
$20.7M
$-4.9M
Q3 24
$16.3M
$9.1M
Q2 24
$7.1M
$13.1M
Q1 24
$10.8M
$7.3M
Free Cash Flow
LOAR
LOAR
MED
MED
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
LOAR
LOAR
MED
MED
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
LOAR
LOAR
MED
MED
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
LOAR
LOAR
MED
MED
Q4 25
2.43×
Q3 25
1.08×
Q2 25
1.42×
-1.36×
Q1 25
1.85×
Q4 24
5.62×
Q3 24
1.89×
8.04×
Q2 24
0.93×
Q1 24
4.81×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LOAR
LOAR

Other$76.8M58%
Commercial Aerospace$21.2M16%
Business Jet And General Aviation$17.6M13%
Defense$16.2M12%

MED
MED

Segment breakdown not available.

Related Comparisons